Propionic Acid

Propionic Acid

SCHEMBL4160919

CCC(=O)O.O=c1[nH]c2ccc(NS(=O)(=O)c3cccc(F)c3)cc2c2cc[nH]c12

nearest known ligand 0.49

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BRD4 O60885 9/20 0.49
JAK1 P23458 1/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.43
ITK Q08881 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC4 P56524 1/20 0.43
HDAC1 Q13547 1/20 0.43
HDAC7 Q8WUI4 1/20 0.43
HDAC2 Q92769 1/20 0.43
HDAC10 Q969S8 1/20 0.43
HDAC11 Q96DB2 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
HDAC9 Q9UKV0 1/20 0.43
HDAC5 Q9UQL6 1/20 0.43
MAPT P10636 3/20 0.42
LMNA P02545 1/20 0.42
TP53 P04637 1/20 0.42
PGR P06401 1/20 0.41
BRAF P15056 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Propionic Acid SCHEMBL4158106 0.91 BRD4 (0.60) BRD4
Propionic Acid SCHEMBL4162506 0.90 BRD4 (0.50) BRD4PTGDR2MAPTLMNATP53
Propionic Acid SCHEMBL4155599 0.90 BRD4 (0.49) BRD4PTGDR2BRAF
Propionic Acid SCHEMBL4157723 0.89 BRD4 (0.62) BRD4JAK1PGR
Propionic Acid SCHEMBL4161141 0.88 BRAF (0.53) BRD4MAPTLMNATP53BRAF
Propionic Acid SCHEMBL4157596 0.88 BRD4 (0.52) BRD4ITKHDAC3HDAC4HDAC1
Propionic Acid SCHEMBL4166797 0.86 PKM (0.43) BRD4JAK1MAPTLMNATP53
Propionic Acid SCHEMBL4167132 0.86 BRAF (0.44) BRD4MAPTLMNATP53BRAF
Propionic Acid SCHEMBL4157756 0.85 BRD4 (0.63) BRD4LMNA
Propionic Acid SCHEMBL4155591 0.85 BRD4 (0.50) BRD4JAK1MAPTLMNATP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US claimed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US claimed
US-8426437-B2 Pyrroloquinoline derivatives and their use as protein kinases inhibitors PIERRE FABRE MEDICAMENT (FR) 2013-04-23 US disclosed
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors PIERRE FABRE MEDICAMENT (FR) 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090042876-A1 Pyrroloquinoline Derivatives And Their Use As Protein Kinases Inhibitors MAP3K1, MAP3K2, MAP3K7 BRD4 545/4885JAK1 136/4885PTGDR2 789/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.